Home Creators Posts Import Register Favorites Logout
haven't archived this post yet. have a subscription? use the importer!

Content

HIMS got hit hard yesterday. I always consider Pharma/Biotech/Med plays super risky and THIS IS NO EXCEPTION. However, it does fall into the disruption category and it is a small flutter for me - less than 0.5% of my portfolio.

After analyzing the data and impact of loss of Weygovy, it should only result in abou 15% loss of revenue.

I entered at $42.15 as I waited for trend to turn. Confluence model also was about to flash a buy signal. I entered a SL . Breakeven on the trade is $45.

bought these

Sold these

The CAGR is extraordinary and I believe it is oversold.

Mean Reversion has never been so low

The Rotation Model also flashing a rotation into it. NFA

Files

Previews only

Comments

Moontastic

Is $HIMS, like a short term trade for you James? Or are you taking a long, multi year bet?

BA Blackwolf

i was wondering why the call was just under a year out, capital gains and all, maybe doesnt matter if you take the shares? or maybe the pricing was best there?